Cargando…
Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis
Flap endonuclease-1 (FEN1), a structure-specific nuclease participating in DNA replication and repair processes, has been confirmed to promote the proliferation and drug resistance of tumor cells. However, the biological functions of FEN1 in cancer cell migration and invasion have not been defined....
Autores principales: | Xu, Lu, Qu, Jing-Lei, Song, Na, Zhang, Ling-Yun, Zeng, Xue, Che, Xiao-Fang, Hou, Ke-Zuo, Shi, Sha, Feng, Zu-Ying, Qu, Xiu-Juan, Liu, Yun-Peng, Teng, Yue-E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610327/ https://www.ncbi.nlm.nih.gov/pubmed/33125141 http://dx.doi.org/10.3892/or.2020.7812 |
Ejemplares similares
-
Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer
por: Xin, Xing, et al.
Publicado: (2020) -
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
por: Al-Kawaz, Abdulbaqi, et al.
Publicado: (2021) -
CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis
por: Cerqueira, Otto L.D., et al.
Publicado: (2015) -
SPARC expression in gastric cancer predicts poor prognosis: Results from a clinical cohort, pooled analysis and GSEA assay
por: Li, Zhi, et al.
Publicado: (2016) -
A bibliometric analysis of researches on flap endonuclease 1 from 2005 to 2019
por: Wei, Qiaochu, et al.
Publicado: (2021)